LOVASTATIN SENSITIZES NON-SMALL CELL LUNG CANCER (NSCLC) CELLS TO RADIATION; POSSIBLE INVOLVEMENT OF THE AKT SIGNALING PATHWAY

被引：0
|
作者：
Tsakiridis, A. [1 ]
Liu, C. [1 ]
Tsiani, E. [2 ]
Singh, G. [1 ]
Wright, J. [1 ]
机构：
[1] Juravinski Canc Ctr, Hamilton, ON, Canada
[2] Dept Community Hlth Sci, St Catharines, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [33] Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells
    Nam, A-Young
    Joo, Sang Hoon
    Khong, Quan T.
    Park, Jisu
    Lee, Na Yeong
    Lee, Seung-On
    Yoon, Goo
    Park, Jin Woo
    Na, Minkyun
    Shim, Jung-Hyun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin
    Lee, Myoung Woo
    Kim, Dae Seong
    Min, Na Young
    Kim, Heung Tae
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2380 - 2384
  • [35] Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
    Stravopodis, Dimitrios J.
    Papavassiliou, Kostas A.
    Papavassiliou, Athanasios G.
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (07): : 2002 - 2005
  • [36] Developing small molecule therapeutics to target AKT signaling in non-small cell lung cancer
    Chandrasekaran, Balaji
    Pal, Deeksha
    Kolluru, Venkatesh
    Ramisetti, Srinivasa R.
    Sharma, Arun K.
    Ankem, Murali
    Damodaran, Chendil
    CANCER RESEARCH, 2017, 77
  • [37] Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP).
    Ellis, Peter G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [38] Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP).
    Ellis, Peter G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Novel biomarkers of non-small cell lung cancer (NSCLC) stem cells
    Karimi-Busheri, Feridoun
    Zadorozhny, Victoria
    Shawler, Daniel L.
    Fakhrai, Habib
    CANCER RESEARCH, 2011, 71
  • [40] PI3K/AKT Signaling Pathway in the Regulation of Non-small Cell Lung Cancer Radiosensitivity After Hypofractionated Radiation Therapy
    Wang, P.
    Liu, N.
    Pang, Q.
    Qu, C.
    Wang, B.
    Guo, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S670 - S670
12345